HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min-Hsiung Pan Selected Research

5-demethylnobiletin

9/2021Dietary 5-demethylnobiletin modulates xenobiotic-metabolizing enzymes and ameliorates colon carcinogenesis in benzo[a]pyrene-induced mice.
5/2011Citrus flavonoid 5-demethylnobiletin suppresses scavenger receptor expression in THP-1 cells and alters lipid homeostasis in HepG2 liver cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min-Hsiung Pan Research Topics

Disease

79Neoplasms (Cancer)
04/2024 - 10/2004
51Inflammation (Inflammations)
04/2024 - 11/2006
36Carcinogenesis
11/2022 - 11/2006
29Obesity
12/2023 - 02/2012
15Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 10/2002
12Breast Neoplasms (Breast Cancer)
01/2021 - 06/2007
12Leukemia
11/2011 - 10/2004
11Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 02/2013
11Body Weight (Weight, Body)
01/2022 - 07/2013
11Neoplasm Metastasis (Metastasis)
01/2021 - 07/2009
10Colitis
03/2024 - 04/2012
10Colonic Neoplasms (Colon Cancer)
01/2022 - 11/2009
8Fibrosis (Cirrhosis)
03/2024 - 06/2013
8Papilloma (Papillomatosis)
02/2014 - 11/2006
7Non-alcoholic Fatty Liver Disease
09/2023 - 01/2014
6Carcinoma (Carcinomatosis)
10/2023 - 02/2005
5Colitis-Associated Neoplasms
01/2021 - 09/2014
5Aberrant Crypt Foci
05/2017 - 08/2010
5Hepatocellular Carcinoma (Hepatoma)
05/2013 - 07/2009
4Necrosis
03/2024 - 06/2015
4Adenocarcinoma
11/2021 - 02/2011
4Insulin Resistance
09/2020 - 01/2014
4Cardiovascular Diseases (Cardiovascular Disease)
10/2019 - 01/2013
3Dysbiosis
04/2024 - 01/2019
3Weight Gain
12/2023 - 10/2015
3Overweight
09/2023 - 01/2017
3Triple Negative Breast Neoplasms
01/2021 - 11/2011
3Hyperlipidemias (Hyperlipidemia)
12/2020 - 01/2013
3Atherosclerosis
10/2019 - 02/2010

Drug/Important Bio-Agent (IBA)

26pterostilbeneIBA
10/2023 - 09/2007
23Proteins (Proteins, Gene)FDA Link
04/2024 - 03/2008
18ResveratrolIBA
05/2023 - 03/2008
14TeaIBA
09/2023 - 06/2007
14CaspasesIBA
04/2011 - 07/2003
13LipidsIBA
12/2023 - 02/2012
12AzoxymethaneIBA
11/2022 - 08/2010
11CurcuminIBA
05/2023 - 09/2010
11Reactive Oxygen Species (Oxygen Radicals)IBA
03/2011 - 02/2005
10Dextran SulfateIBA
03/2024 - 04/2012
10PhytochemicalsIBA
10/2023 - 06/2012
10anthraceneIBA
01/2021 - 11/2006
9EnzymesIBA
03/2024 - 11/2008
9Triglycerides (Triacylglycerol)IBA
03/2024 - 01/2014
9Messenger RNA (mRNA)IBA
01/2022 - 01/2010
8StilbenesIBA
11/2021 - 03/2008
8garcinolIBA
01/2021 - 12/2010
7CytokinesIBA
03/2024 - 10/2010
7PolyphenolsIBA
12/2019 - 06/2007
6CholesterolIBA
03/2024 - 04/2016
63'-hydroxypterostilbeneIBA
10/2023 - 01/2014
63,3',4,5'-tetrahydroxystilbeneIBA
02/2023 - 10/2016
6AntioxidantsIBA
01/2023 - 07/2009
6sodium sulfate (sodium bisulfate)FDA LinkGeneric
11/2022 - 01/2017
6Dextrans (Dextran)FDA Link
11/2022 - 01/2017
5CollagenIBA
03/2024 - 01/2012
5Dimethylnitrosamine (Nitrosodimethylamine)IBA
03/2024 - 02/2013
5FlavonoidsIBA
09/2023 - 03/2013
5Carbon Tetrachloride (Tetrachloromethane)IBA
11/2021 - 09/2017
5Insulin (Novolin)FDA Link
01/2021 - 01/2014
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2021 - 06/2007
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 02/2011
5Antineoplastic Agents (Antineoplastics)IBA
08/2016 - 12/2007
55- hydroxy- 3,6,7,8,3',4'- hexamethoxyflavoneIBA
10/2011 - 06/2007
4Ethanol (Ethyl Alcohol)IBA
03/2024 - 05/2013
4Blood Glucose (Blood Sugar)IBA
12/2023 - 09/2018
4CarcinogensIBA
09/2021 - 05/2017
4Therapeutic UsesIBA
01/2020 - 03/2008
4tetrahydrocurcuminIBA
01/2020 - 11/2011
4Dronabinol (THC)FDA LinkGeneric
12/2018 - 11/2011
4Cyclin D1IBA
05/2017 - 02/2011
4NicotineFDA Link
04/2016 - 01/2010
4ErbB Receptors (EGF Receptor)IBA
11/2012 - 06/2007
4shogaolIBA
09/2010 - 05/2008
4Cytochromes c (Cytochrome c)IBA
11/2007 - 07/2003
3Benzo(a)pyreneIBA
10/2023 - 01/2018
3Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
10/2023 - 09/2021
3calebin-AIBA
03/2023 - 10/2015
3InflammasomesIBA
02/2023 - 01/2020
3Polysaccharides (Glycans)IBA
01/2022 - 08/2010
3XenobioticsIBA
09/2021 - 01/2018
3Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2021 - 03/2008
3Carnitine (L-Carnitine)FDA LinkGeneric
09/2020 - 07/2019
3trimethyloxamine (trimethylamine N-oxide)IBA
10/2019 - 06/2019
3nobiletinIBA
06/2019 - 02/2010
3Transaminases (Aminotransferases)IBA
02/2018 - 11/2014
3Hormones (Hormone)IBA
01/2018 - 03/2011
3CateninsIBA
05/2017 - 02/2011
3Transcription Factors (Transcription Factor)IBA
11/2016 - 02/2011
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2013 - 02/2011
3NF-kappa B (NF-kB)IBA
01/2012 - 11/2006
3Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
03/2011 - 01/2010
3gingerolIBA
09/2010 - 05/2008
3Glutathione (Reduced Glutathione)IBA
03/2010 - 08/2006
2Transforming Growth Factors (Transforming Growth Factor)IBA
03/2024 - 01/2022
2ethyl acetateIBA
03/2024 - 11/2007

Therapy/Procedure

15Chemoprevention
10/2023 - 06/2007
7Therapeutics
01/2022 - 12/2010
5Drug Therapy (Chemotherapy)
05/2023 - 03/2008
4Oral Administration
04/2020 - 06/2013
2Aftercare (After-Treatment)
03/2024 - 04/2019